the Pathophysiology of the Onset of Atrial Fibrillation in Obstructive Sleep Apnea
NCT ID: NCT06246825
Last Updated: 2024-02-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
190 participants
OBSERVATIONAL
2020-12-01
2024-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mechanisms for Atrial Fibrillation in Obstructive Sleep Apnea
NCT06465134
Influence of Sleep Apnea on Risk of Atrial Fibrillation
NCT02576587
Sleep-related Breathing Disorders in Cardiological Outpatients
NCT02693925
Prospective Observational Registry for Obstructive Sleep Apnea in Patients With Acute Myocardial Infarction
NCT03600246
Right Ventricular Function in Patients With Obstructive Sleep Apnea
NCT01201200
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PARABOLA cohort
Patients with paroxysmal or persistent atrial fibrillation and a high likelihood of obstructive sleep apnea
Polysomnography
Patients with a high likelihood of having obstructive sleep apnea will undergo a polysomnography, as recommended by the guidelines
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Polysomnography
Patients with a high likelihood of having obstructive sleep apnea will undergo a polysomnography, as recommended by the guidelines
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
AND
* STOP-BANG score \>5 or STOP-BANG \>4 and typical nocturnal onset of AF
* A positive WATCH-PAT screening
* very high clinical suspicion of OSA, with STOP-BANG score \>3
Exclusion Criteria
* Reversible cause of AF
* severe lung disease (COPD Gold IV, pumonary fibrosis, lobectomy) wever esophageal disease (malignancy, stricture, esophagectomy)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Catharina Ziekenhuis Eindhoven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maarten van den Broek
Mr JLPM van den Broek, MD, Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lukas RC Dekker, MD, PhD, prof
Role: STUDY_CHAIR
Eindhoven University of Technology / Catharina Hospital Eindhoven
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Catharina Ziekenhuis
Eindhoven, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CatharinaZE_PARABOLA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.